<DOC>
	<DOCNO>NCT00548925</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy 6 mg twice day dose investigational product subject diabetic neuropathy</brief_summary>
	<brief_title>A Safety Efficacy Study Subjects With Diabetic Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<criteria>Males female , age 18 75 If female , must nonchildbearing potential practice birth control Has diabetes mellitus ( Type 1 2 ) diagnosis painful distal symmetric diabetic polyneuropathy Has pain distal symmetric diabetic polyneuropathy minimum 6 month Must willing washout analgesic medication prior entry study Has condition may cause pain Currently receive analgesic medication condition diabetic neuropathic pain Has history certain psychiatric disease Has history certain heart cardiovascular condition Has clinically significant recent infection , injury , illness Current participation another clinical study participation within past 30 day Is incapacitate , bedridden confine wheelchair Is pregnant and/or breastfeed Previous participation study study investigational product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>